Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form

Biomind Labs Inc. announces today the Company’s completion of the development of a novel thermosensitive nasal gel delivery system for its N, N-dimethyltryptamine (“DMT”) and 5-MeO-DMT product candidates.